What is RPD's health score?

Rapid7, Inc. (RPD) has a TradeApes health score of 54 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RPD's estimated fair value?

Based on our 5-year discounted cash flow model, Rapid7, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is RPD undervalued or overvalued?

Our model currently rates RPD as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RPD... Refresh in a moment for the full analysis.

Rapid7, Inc. (RPD)

Technology Inconclusive inconclusive mixed

$7.67

Updated: 2026-06-04

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

58 Mixed

Relative Value

73 Healthy

Capital Allocation

35 Weak

Risk

50 Mixed

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.